By proceeding, you agree to our Terms of Use and Privacy Policy.
Jon Hollick is currently working as Managing Director & Head of Research at Breakpoint Therapeutics GmbH.
Talks About #medicinalchemistry #drugdiscovery
Preferred Locations #Northamerica
The 6th DDR Inhibitors Summit 2023 is the premier event for pharmaceutical and biotech researchers to discuss advances, challenges, and new solutions in the field of DDR inhibitors.